Photodynamic therapy simplified: Nonprepared, moderate-grade actinic keratosis lesions respond equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions

British Journal of Dermatology

Volumn 173, Issue 5, 2015, Pages 1277-1279

  Szeimies, R M ^a   Hauschild, A ^b   Ortland, C ^c   Moor, A C E ^d   Stocker, M ^d   Surber, C ^e,f  

^a Klinikum Vest Academic Teaching Hospital   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Das Forschungsdock   (Germany)

^d Mogensen GmbH and Co KG   (Germany)

^e Universitatsspital Basel Dermatologie   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PLACEBO; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ARTICLE; CORRELATIONAL STUDY; CRYOSURGERY; CRYOTHERAPY; DRUG FORMULATION; HUMAN; HYPERKERATOSIS; HYPERPIGMENTATION; HYPOPIGMENTATION; INVESTIGATIVE PROCEDURES; PERSONAL EXPERIENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; TREATMENT RESPONSE; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY; PROCEDURES; TRANSDERMAL PATCH; TREATMENT OUTCOME;

AMINOLEVULINIC ACID; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84983095637     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13889     Document Type: Article

References (10)

1. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic keratosis'). J Am Acad Dermatol 2000; 42: 11-17.
2. Olsen EA, Abernethy ML, Kulp-Shorten C, et al,. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-43.
3. Jeffes EW, McCullough JL, Weinstein GD, et al,. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45: 96-104.
4. Dirschka T, Radny P, Dominicus R, et al,. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol 2013; 168: 825-36.
5. Tarstedt M, Rosdahl I, Berne B, et al,. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005; 85: 424-8.
6. Fauteck JD, Ackermann G, Birkel M, et al,. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res 2008; 300: 53-60.
7. Hauschild A, Popp G, Stockfleth E, et al,. Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp Dermatol 2009; 18: 116-21.
8. Hauschild A, Stockfleth E, Popp G, et al,. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 2009; 160: 1066-74.
9. Szeimies RM, Stockfleth E, Popp G, et al,. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol 2010; 162: 410-14.
10. Szeimies RM, Matheson RT, Davis SA, et al,. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study. Dermatol Surg 2009; 35: 1066-74.